1. Home
  2. TVTX vs HCI Comparison

TVTX vs HCI Comparison

Compare TVTX & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$33.94

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo HCI Group Inc.

HCI

HCI Group Inc.

HOLD

Current Price

$174.80

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
HCI
Founded
2008
2006
Country
United States
United States
Employees
N/A
552
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TVTX
HCI
Price
$33.94
$174.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$37.21
$230.00
AVG Volume (30 Days)
1.5M
166.1K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
0.93%
EPS Growth
N/A
32.29
EPS
N/A
15.80
Revenue
$435,826,000.00
$816,578,000.00
Revenue This Year
$120.36
$19.65
Revenue Next Year
$37.33
$9.97
P/E Ratio
N/A
$10.94
Revenue Growth
114.22
8.75
52 Week Low
$12.91
$106.89
52 Week High
$37.50
$210.50

Technical Indicators

Market Signals
Indicator
TVTX
HCI
Relative Strength Index (RSI) 50.01 45.34
Support Level $34.00 $168.93
Resistance Level $35.79 $181.51
Average True Range (ATR) 1.43 5.21
MACD -0.47 0.29
Stochastic Oscillator 10.00 56.10

Price Performance

Historical Comparison
TVTX
HCI

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

Share on Social Networks: